In contrast to our findings, Dhillon and colleagues reported that IL-33 levels were not correlated with adverse outcomes in non-ST-elevation myocardial infarction (NSTEMI) patients [25]. The gene discussed is IL33; the disease is ST Elevation Myocardial Infarction.